Report: Cook stent meets safety, effectiveness goals

Zilver PTX, a drug-coated stent from Cook Medical, met safety and effectiveness goals for treating blocked femoral arteries, FDA staff said. Their findings came in a report issued ahead of an Oct. 13 meeting of outside experts who will weigh in on whether to clear the device. The device would be the first drug-coated stent approved in the U.S. to treat peripheral vascular disease in the largest artery of the upper leg. News

Suggested Articles

Medtronic has moved to acquire Avenu Medical, developers of a minimally invasive method of building the blood vessel access ports.

The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing.

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.